cocaine has been researched along with fluorodopa f 18 in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babchyck, B; Chaly, T; Dhawan, V; Eidelberg, D; Ishikawa, T; Kazumata, K; Mandel, F; Margouleff, C; Neumeyer, J; Zanzi, I | 1 |
| Bergmans, P; Booij, J; Stoof, JC; Tissingh, G; Van Royen, EA; Winogrodzka, A; Wolters, EC | 1 |
| Bell, K; Bunney, BG; Bunney, WE; Fallon, J; Keator, D; Klein, E; Najafi, A; Tang, C; Widmark, C; Wu, JC | 1 |
| Cumming, P; Gjedde, A; Reith, J | 1 |
| Chen, A; Cumming, P; Dagher, A; Deep, P; Gjedde, A; Kapczinski, F; Reutens, D; Wong, DF; Yokoi, F | 1 |
| Bergman, J; Eskola, O; Nurmi, E; Rinne, OJ; Ruottinen, HM; Solin, O | 1 |
| Seibyl, JP | 1 |
| Pirker, W | 1 |
| Brooks, DJ; Frey, KA; Marek, KL; Oakes, D; Paty, D; Prentice, R; Shults, CW; Stoessl, AJ | 1 |
| Ahlskog, JE; Albin, RL; Brooks, DJ; Carbon, M; Dhawan, V; Eidelberg, D; Fahn, S; Feigin, A; Guttman, M; Gwinn-Hardy, K; Holloway, R; Innis, R; Katz, RG; Kieburtz, K; Kish, SJ; Lange, N; Langston, JW; Marek, K; McFarland, H; Morin, L; Moy, C; Murphy, D; Oertel, WH; Oliver, G; Palesch, Y; Powers, W; Ravina, B; Seibyl, J; Sethi, KD; Sheehy, P; Shults, CW; Stoessl, AJ | 1 |
| Broussolle, E; Remy, P; Thobois, S | 1 |
| Deleu, D; Hanssens, Y | 1 |
| Ebadi, M; Govitrapong, P; Klongpanichapak, S; Sharma, SK | 1 |
4 review(s) available for cocaine and fluorodopa f 18
| Article | Year |
|---|---|
Imaging studies in movement disorders.
Topics: Brain; Cocaine; Dihydroxyphenylalanine; Dopamine; Humans; Movement Disorders; Parkinson Disease; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease.
Topics: Animals; Basal Ganglia; Biomarkers; Cocaine; Diagnostic Imaging; Dihydroxyphenylalanine; Disease Progression; Dopamine Plasma Membrane Transport Proteins; Humans; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuropeptides; Parkinson Disease; Radiopharmaceuticals; Technology Assessment, Biomedical; Tetrabenazine; Tomography, Emission-Computed, Single-Photon; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2003 |
The role of radiotracer imaging in Parkinson disease.
Topics: Biomarkers; Biotransformation; Blood-Brain Barrier; Carbon Radioisotopes; Clinical Trials as Topic; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neurons; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Dopamine; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed, Single-Photon | 2005 |
[Advantages and limitations in the assessment of neuroprotective treatment of Parkinson's disease by functional imaging].
Topics: Antiparkinson Agents; Cocaine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Parkinson Disease; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2005 |
1 trial(s) available for cocaine and fluorodopa f 18
| Article | Year |
|---|---|
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal.
Topics: Adult; Brain Chemistry; Cocaine; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Humans; Male; Narcotics; Neostriatum; Substance Withdrawal Syndrome; Tomography, Emission-Computed | 1997 |
8 other study(ies) available for cocaine and fluorodopa f 18
| Article | Year |
|---|---|
Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Topics: Adult; Aged; Aging; Carrier Proteins; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
Topics: Aging; Carrier Proteins; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1997 |
Cocaine withdrawal and the cerebral influx of [18F]fluoro-L-DOPA (FDOPA)
Topics: Brain Chemistry; Cocaine; Dihydroxyphenylalanine; Dopamine Uptake Inhibitors; Fluorine Radioisotopes; Humans; Substance Withdrawal Syndrome | 1999 |
Pharmacokinetics of radiotracers in human plasma during positron emission tomography.
Topics: Benzazepines; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Cocaine; Dihydroxyphenylalanine; Dopamine Antagonists; Drug Interactions; Fluorine Radioisotopes; Humans; Nicotine; Raclopride; Radiopharmaceuticals; Selegiline; Tomography, Emission-Computed | 1999 |
[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Topics: Aged; Brain; Caudate Nucleus; Cocaine; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Female; Fluorine Radioisotopes; Functional Laterality; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Presynaptic Terminals; Putamen; Synaptic Transmission | 2001 |
Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
Topics: Activities of Daily Living; Aged; Brain; Cocaine; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Dominance, Cerebral; Dopamine Plasma Membrane Transport Proteins; Female; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Neural Pathways; Neurologic Examination; Parkinson Disease; Sensitivity and Specificity; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2003 |
Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.
Topics: Animals; Antiparkinson Agents; Cocaine; Dihydroxyphenylalanine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Duodenum; Humans; Indoles; Infusion Pumps; Levodopa; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2006 |
Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10.
Topics: alpha-Synuclein; Animals; Central Nervous System Stimulants; Cocaine; Coenzymes; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Electron Transport Complex I; Immunoblotting; Lipid Peroxidation; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Microdialysis; Reactive Oxygen Species; Tyrosine 3-Monooxygenase; Ubiquinone | 2006 |